Table 1.
Targeted gene | Expression | Delivery system | Cell line | Animal model | Methods | Effect on | Reference |
---|---|---|---|---|---|---|---|
CIP2A | Up | 599 peptide (viroporins) + Lipofectamine | CAL 27 and SCC-25 | – | Agarose gel shift assay, fluorescence microscopy, RT-PCR, Western blot, CellTiter kit for cell proliferation, CytoSelect 24-well cell invasion assay kit, anchorage-independent growth assay | Regulate anchorage- independent growth and inhibition of invasion | 42 |
Cip2A | Up | EGFR-binding peptide and endosome-disruptive peptide | CAL 27 and SCC-15 | Nude mice | Cell proliferation assay, hydrodynamic diameter and zeta potential measurement, BIO-RAD ChemiDoc XRS system | Prevent invasion and tumor growth | 28 |
CxcR4 | Up | Lentiviral vectors | SCC-9, SCC-4, and Tca8113 cell lines | Nude mice | RT-PCR, Western blot, propidium iodide staining for cell cycle, Annexin V for apoptosis, CCK8, IHC, and microarray | Regulate cell cycle and proliferation | 67 |
VEGF | Up | Folic acid-decorated polyamidoamine dendrimer G4 | HN-12 | Female athymic nude mice | ELISA, qRT-PCR, tumor size, H&E staining | Inhibit angiogenesis | 68 |
MDR1 and MDR2 | Up | Adeno-associated viral vector | KB | No | RT-PCR, Western blot, flow cytometry, MTT assay | Regulate MDR | 51 |
MDR1 | Up | Polymer polyethylenimine | Doxorubicin | KBV cells, BALB/c nude mice | Cytotoxicity assays in vitro, drug loading rate and release assays, agarose gel retardation assay, qRT-PCR, apoptosis by flow cytometry | Regulate MDR | 69 |
Abbreviations: CCK8, cell counting kit 8; EGFR, epidermal growth factor receptor; ELISA, enzyme-linked immunosorbent assay; IHC, immunohistochemistry; MDR, multidrug resistance; KBV, oral squamous cells; qRT-PCR, quantitative reverse transcriptase polymerase chain reaction; siRNA, small interfering RNA.